Loading...
XHKG
0829
Market cap65mUSD
Jul 10, Last price  
0.16HKD
1D
-1.25%
1Q
-13.66%
Jan 2017
-73.22%
IPO
-92.49%
Name

Shenguan Holdings (Group) Ltd

Chart & Performance

D1W1MN
XHKG:0829 chart
P/E
—
P/S
0.43
EPS
—
Div Yield, %
25.00%
Shrs. gr., 5y
—
Rev. gr., 5y
1.25%
Revenues
1.02b
+0.64%
454,053,000794,418,0001,152,689,0001,501,985,0001,648,477,0001,654,492,0001,403,008,0001,054,565,000980,617,0001,007,991,000899,016,000997,500,000961,623,0001,168,099,0001,032,155,0001,110,412,0001,016,812,0001,023,274,000
Net income
-70m
L
220,775,000376,141,000513,458,000689,319,000748,183,000771,277,000547,476,000291,390,000154,163,00068,794,00080,259,00075,444,00090,754,000122,652,00023,565,00031,242,00026,664,000-69,773,000
CFO
-93m
L-35.30%
265,840,000355,788,000386,622,000696,578,000763,166,000467,471,000280,846,000327,435,000311,996,000422,449,000282,109,000321,105,000443,144,000179,708,000106,044,000176,447,000-143,254,000-92,680,593
Dividend
Jun 10, 20250.04 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shenguan Holdings (Group) Limited operates as an investment holding company, with its core business centered on the manufacturing and global distribution of edible collagen sausage casings. The company serves markets across Mainland China, the broader Asian region, and various international territories. Beyond casings, Shenguan diversifies its manufacturing portfolio to include a range of products intended for human consumption and application. This includes pharmaceuticals and their intermediates, various food items, specialized skin care and health products, bioactive collagen solutions, and precision fine chemicals. Established in 2009, the firm is headquartered in Causeway Bay, Hong Kong. Shenguan Holdings (Group) Limited is a subsidiary of Rich Top Future Limited.
URL
http://www.shenguan.com.hk/
IPO date
Oct 13, 2009
Employees
2,650
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT